Cancer researchers can use whole genome, exome, and targeted amplicon next generation sequencing approaches to characterize cancer-associated mutations and other biomarkers.
Synthetic biologists are testing nucleotide and amino acid-level variations in target genes to gain understanding of protein function in oncogenesis.
Azenta offers a number of genomics solutions to assist in cancer research and discovery at different stages of your research.
Azenta offers several cancer panels to provide a complete solution from experimental design to advanced bioinformatics analysis. These include commercially available hotspot cancer panels, as well as Azenta’s pan-cancer and OncoGxOne™ discovery cancer panels.
We offer a range of Sanger sequencing options available to meet the cancer researcher’s basic toolkit needs. From PCR purification to direct-colony sequencing, GENEWIZ’s fast turnaround and high-quality data will accelerate the pace of your cancer-related sequence confirmation needs.
Gene Synthesis services offer cancer researchers a way to characterize the effects of genomic mutations upon the mechanisms of cellular functions. An alternative to molecular cloning, gene synthesis affords cancer researchers a quicker way to generate constructs to test in vitro the impact of nucleotide and amino acid-level changes on the mechanisms of cancer.